Literature DB >> 9241948

Antisaccade performance in patients with schizophrenia and affective disorder.

J Katsanis1, S Kortenkamp, W G Iacono, W M Grove.   

Abstract

The authors examined psychotic patients with schizophrenia, major depression, and bipolar disorder; "normal" participants; and 1st-degree relatives of patients with schizophrenia on an antisaccade task in which participants were instructed to move their eyes in the opposite direction of a target that moved unpredictably and abruptly either to the left or right of central fixation. Patients with schizophrenia were found to make significantly more errors than their relatives, and the latter made more errors than the controls. The poor performance of the relatives could not be attributed to their having a psychiatric disorder. Comparison of the 3 patient groups indicated that antisaccade deficits were more pronounced in schizophrenia and bipolar disorder.

Entities:  

Mesh:

Year:  1997        PMID: 9241948     DOI: 10.1037//0021-843x.106.3.468

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  20 in total

1.  Smooth pursuit and saccadic eye movement performance in a prefrontal leukotomy patient.

Authors:  D C Gooding; W G Iacono; D R Hanson
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

2.  The antisaccade task and neuropsychological tests of prefrontal cortical integrity in schizophrenia: empirical findings and interpretative considerations.

Authors:  Deborah L Levy; Nancy R Mendell; Philip S Holzman
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

3.  Common neural circuitry supporting volitional saccades and its disruption in schizophrenia patients and relatives.

Authors:  Jazmin Camchong; Kara A Dyckman; Benjamin P Austin; Brett A Clementz; Jennifer E McDowell
Journal:  Biol Psychiatry       Date:  2008-08-09       Impact factor: 13.382

4.  Does performance on the standard antisaccade task meet the co-familiality criterion for an endophenotype?

Authors:  Deborah L Levy; Elizabeth A Bowman; Larry Abel; Olga Krastoshevsky; Verena Krause; Nancy R Mendell
Journal:  Brain Cogn       Date:  2008-10-07       Impact factor: 2.310

Review 5.  Eye tracking dysfunction in schizophrenia: characterization and pathophysiology.

Authors:  Deborah L Levy; Anne B Sereno; Diane C Gooding; Gilllian A O'Driscoll
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 6.  Rapid-response impulsivity: definitions, measurement issues, and clinical implications.

Authors:  Kristen R Hamilton; Andrew K Littlefield; Noelle C Anastasio; Kathryn A Cunningham; Latham H L Fink; Victoria C Wing; Charles W Mathias; Scott D Lane; Christian G Schütz; Alan C Swann; C W Lejuez; Luke Clark; F Gerard Moeller; Marc N Potenza
Journal:  Personal Disord       Date:  2015-04

7.  Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.

Authors:  Haraldur Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Andres Ingason; Hannes Petursson
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

Review 8.  Neurocognitive allied phenotypes for schizophrenia and bipolar disorder.

Authors:  S Kristian Hill; Margret S H Harris; Ellen S Herbener; Mani Pavuluri; John A Sweeney
Journal:  Schizophr Bull       Date:  2008-04-29       Impact factor: 9.306

9.  Attentional facilitation of response is impaired for antisaccades but not for saccades in patients with schizophrenia: implications for cortical dysfunction.

Authors:  Nikolaos Smyrnis; Ioannis A Malogiannis; Ioannis Evdokimidis; Nicholas C Stefanis; Christos Theleritis; Alexandros Vaidakis; Stavroula Theodoropoulou; Costas N Stefanis
Journal:  Exp Brain Res       Date:  2004-06-24       Impact factor: 1.972

10.  Eye movement deficits in schizophrenia: investigation of a genetically homogenous Icelandic sample.

Authors:  H Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Hannes Petursson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.